Walmsley was three years into her effort remaking ... Revenue increased 8% in the first half of 2020—powered by the growth of its consumer health division, largely owing to its merger with ...
Bloomberg on MSN9mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...
Hosted on MSN1mon
GSK CEO Optimistic About Dealmaking, Trump Administration(Bloomberg) -- GSK Plc’s Chief Executive Officer Emma Walmsley is looking to do more deals as the British drugmaker doubles down on its return to cancer medicines. While GSK already agreed to ...
GlaxoSmithKline chief executive Emma Walmsley is among more than 100 prominent ... positions at FTSE 350 companies should go to women by 2020. Pharma has a mixed performance in terms of ...
GlaxoSmithKline’s new chief executive Emma Walmsley has unveiled her strategy ... to eliminate a further £1billion in savings by 2020. The company says it is sticking with its growth forecast ...
CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights the U.K. pharmaceutical company's refocused R&D strategy, with investments concentrated in the U.K., U.S ...
Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work is starting to pay off. Much credit goes to Arexvy, GSK’s first-on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback